Developing Next-generation Cancer Treatments
Therapeutic Portfolio
![](https://cdn.prod.website-files.com/64c9af957e453c8bae438e23/64d14a3ac38e2a84ce32559b_Frame%204%20(4).webp)
Prostate Cancer
![](https://cdn.prod.website-files.com/64c9af957e453c8bae438e23/64d14a3afb27bb254f11d292_Frame%204%20(5).webp)
Melanoma
![](https://cdn.prod.website-files.com/64c9af957e453c8bae438e23/64d14a3a9333810c9086b828_Frame%204%20(6).webp)
Pancreatic and Breast Cancer
Delivering an Unmatched
Supply of Alpha Isotopes
ALPHA 212
Alpha 212 is the isotope Lead-212 or ²¹²Pb and powers AdvanCell's therapeutic pipeline.
AdvanCell routinely manufactures Alpha 212 through a fleet of ²¹²Pb Generators enabling full control of the supply chain for the global manufacture of targeted alpha therapies.
![](https://cdn.prod.website-files.com/64c9af957e453c8bae438e23/64d29da4eddc6661ee74fb7a_Content%20(4).webp)